Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",18642,146,0.65 [0.38-1.12],0.1240075822511706
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19603,203,1.37 [0.88-2.12],0.1627988681824584
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19376,1411,1.25 [1.06-1.48],0.0097308019718476
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,19617,444,1.24 [0.92-1.67],0.1659544582024369
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,18969,3450,1.15 [1.03-1.29],0.0117680663298463
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),18951,3505,1.45 [1.31-1.61],6.114482851693141e-12
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19372,1159,1.48 [1.23-1.78],2.26115872081779e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,19530,107,1.85 [1.05-3.26],0.031946885619233
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,17304,1025,1.35 [1.11-1.65],0.0032626707005344
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,16669,1234,1.81 [1.53-2.15],6.7165781125563636e-12
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,16332,268,1.63 [1.12-2.38],0.0105909319557944
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,12770,2215,1.42 [1.25-1.62],1.35450623888054e-07
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,16279,392,2.38 [1.81-3.12],3.987881697926051e-10
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,19585,1372,1.44 [1.22-1.71],1.6572153265524346e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Mycoses,19687,514,1.19 [0.90-1.58],0.2240638597724763
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,18962,997,1.18 [0.97-1.45],0.101446544365739
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,19629,1133,1.20 [0.99-1.45],0.0652281739872588
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18416,203,1.40 [0.90-2.17],0.1303181485137838
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,19738,51,1.03 [0.41-2.55],0.9569829033785578
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,19485,989,1.24 [1.01-1.52],0.0375122912432743
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19488,65,1.25 [0.58-2.73],0.5676955062716933
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,19683,112,0.97 [0.53-1.79],0.9238975365145856
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19668,97,1.24 [0.65-2.36],0.517855002004413
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18352,387,1.52 [1.10-2.09],0.0110515700268091
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,18216,251,1.56 [1.05-2.31],0.0267035959837722
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,18315,102,2.58 [1.58-4.21],0.0001409084152568
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,19723,47,0.79 [0.31-2.01],0.615249852410692
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,19677,146,1.24 [0.73-2.10],0.4198390200164065
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Viral warts,19579,48,1.50 [0.61-3.71],0.3775539444599907
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],19602,71,1.00 [0.47-2.13],0.9945563362348834
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign lipomatous neoplasm,19498,221,0.82 [0.53-1.28],0.3857832711980651
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19667,38,1.36 [0.49-3.78],0.5529947633772623
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19650,38,0.98 [0.34-2.82],0.9744040343341164
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,9326,67,0.52 [0.24-1.13],0.0982821176605674
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19349,1413,1.07 [0.90-1.28],0.4144662819067037
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm of meninges,19725,57,0.80 [0.33-1.91],0.6134596355034578
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19658,71,2.00 [1.00-3.99],0.0500072075328547
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,19716,101,1.06 [0.56-2.00],0.869233627384522
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm of ovary,10362,65,1.04 [0.47-2.32],0.917450246950937
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,19703,380,1.21 [0.87-1.68],0.2511855333553024
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Caecum,19715,326,1.15 [0.81-1.65],0.4323430283202373
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19612,76,0.79 [0.38-1.67],0.5411748749691726
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,19702,218,1.05 [0.68-1.63],0.8325165907080005
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Rectum,19659,341,1.31 [0.93-1.85],0.1254593147761852
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19609,594,1.28 [0.98-1.66],0.0669270582472284
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,19694,449,1.11 [0.82-1.51],0.4860995865640384
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Carcinoma in situ of breast,7807,44,0.43 [0.15-1.22],0.1120267798165121
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",7840,54,0.97 [0.38-2.45],0.944777048298396
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",14149,63,0.59 [0.25-1.39],0.2294438673484605
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",14169,83,0.79 [0.37-1.65],0.5264157266527167
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",19687,109,0.62 [0.33-1.17],0.1412441898689194
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Haemangioma, any site",19688,106,0.60 [0.32-1.14],0.1198400344279336
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Leiomyoma of uterus,10128,146,1.07 [0.62-1.83],0.8053153682299257
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Lung cancer and mesothelioma,12580,421,1.01 [0.73-1.39],0.9590642072255444
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Lymphoid leukaemia,14149,63,0.56 [0.24-1.31],0.1779476924648038
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",14272,186,0.99 [0.60-1.62],0.9598099376295494
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",14339,253,0.80 [0.52-1.21],0.2892928096544182
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",7921,97,2.39 [1.29-4.45],0.0059329340738987
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",14181,95,0.86 [0.43-1.71],0.6658612607561408
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",14210,124,1.68 [0.95-2.99],0.0753305515001167
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",14197,111,0.92 [0.49-1.74],0.8001580883076239
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",7902,78,0.78 [0.36-1.68],0.5297848965946579
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",14194,108,0.90 [0.47-1.72],0.749810585450876
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",7068,806,0.79 [0.63-1.00],0.0532730277036235
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",14197,111,1.05 [0.56-1.99],0.8738014642733276
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",14167,81,1.21 [0.59-2.48],0.6059205656620279
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,14204,118,0.82 [0.44-1.53],0.5419816846742612
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Melanocytic naevi,19612,159,1.27 [0.77-2.10],0.3516933522226001
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Melanocytic naevi of trunk,19715,66,1.81 [0.86-3.80],0.1189995752630214
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Melanoma in situ,14132,98,0.68 [0.34-1.36],0.2759568894171695
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",14190,104,0.81 [0.42-1.58],0.540950338606697
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",14257,171,0.97 [0.58-1.62],0.9081249590157484
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",14380,294,0.88 [0.60-1.29],0.4974503694323174
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",14197,111,1.74 [0.95-3.19],0.0735848738627713
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Other benign neoplasms of skin,19595,143,0.94 [0.54-1.62],0.8224292031047336
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",15330,1244,1.04 [0.86-1.26],0.6556531436491928
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",15396,1310,1.01 [0.84-1.22],0.8979931587644674
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19483,319,0.76 [0.53-1.10],0.1459433552310312
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,17834,105,2.86 [1.72-4.73],4.726727284933508e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,19223,59,1.61 [0.72-3.58],0.2477249986960056
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19124,2881,1.20 [1.06-1.35],0.0035444496407759
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,18330,60,1.33 [0.59-2.99],0.4843112201245585
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19352,60,1.36 [0.60-3.08],0.4660043205896591
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19337,1608,1.28 [1.09-1.50],0.002299305549481
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19335,1606,1.28 [1.09-1.50],0.0025156147252773
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,17822,93,1.06 [0.54-2.08],0.8583567303491121
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19438,1168,1.40 [1.16-1.68],0.0003575223822582
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19390,98,0.84 [0.43-1.62],0.5973213406667875
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,19223,59,1.28 [0.56-2.90],0.5564198606145161
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,19231,67,0.59 [0.26-1.33],0.2059683820605351
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,19586,294,1.23 [0.85-1.78],0.2688310297491668
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,19632,32,1.11 [0.35-3.50],0.8614282663365697
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19530,238,1.06 [0.70-1.61],0.7753970136721109
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,18380,110,0.99 [0.53-1.84],0.968469530099418
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,13397,329,1.95 [1.43-2.67],2.888878369436951e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18476,85,0.72 [0.33-1.57],0.4087035736158589
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18481,90,0.67 [0.33-1.36],0.2680023374931692
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,13130,62,0.98 [0.42-2.27],0.9565855892598424
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,18390,42,0.71 [0.26-1.94],0.5008692672079891
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,17768,266,1.20 [0.81-1.78],0.3585016886208059
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",19097,747,1.03 [0.82-1.31],0.7888724961230469
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,18757,407,1.04 [0.76-1.43],0.808863147769844
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,18495,145,0.66 [0.39-1.14],0.1395567442310281
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19515,1167,1.16 [0.96-1.40],0.1191599041705376
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,16709,1137,1.14 [0.94-1.38],0.1922088300237138
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",13132,64,1.67 [0.78-3.59],0.1856677162590979
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",17829,84,0.67 [0.33-1.40],0.2890180217574019
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,13368,300,1.54 [1.08-2.20],0.0162626571597016
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,13115,47,0.95 [0.36-2.50],0.9196471492419304
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,16886,3818,1.12 [1.01-1.25],0.0290705975755479
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,13292,224,1.04 [0.67-1.62],0.8542993110052963
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,13650,582,1.34 [1.03-1.75],0.0274081012998708
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19692,302,1.78 [1.26-2.52],0.0010815106294007
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,19512,122,3.48 [2.32-5.23],1.651094526425377e-09
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,13189,121,0.76 [0.41-1.40],0.3744738015621401
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",13136,68,1.41 [0.67-2.98],0.3620727597243323
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,19198,1453,1.19 [1.00-1.40],0.0471764422059588
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,13380,312,2.05 [1.48-2.84],1.382718518775565e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,13389,321,3.68 [2.93-4.63],3.863657411907567e-29
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",13781,713,1.23 [0.97-1.57],0.0902939686996423
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,13195,127,1.13 [0.63-2.00],0.6825878705328638
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19507,117,3.33 [2.18-5.09],2.8113552576525682e-08
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,13817,749,1.04 [0.82-1.33],0.7330569199601613
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,13600,532,0.89 [0.67-1.19],0.4405250402815791
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,17560,58,2.41 [1.21-4.83],0.0128115145674976
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18427,5359,1.16 [1.06-1.27],0.0008095361756382
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,17793,48,0.58 [0.22-1.51],0.2621097095265487
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,17791,46,0.49 [0.18-1.33],0.1627120297582133
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,19594,1554,1.05 [0.89-1.24],0.5578755789519372
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",19592,1552,1.05 [0.89-1.24],0.535455757522243
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,17800,55,1.30 [0.56-3.03],0.5388031028419025
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19436,957,1.11 [0.90-1.37],0.31289545778397
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",14898,1830,1.31 [1.13-1.52],0.0003575692985795
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,19727,241,2.38 [1.68-3.39],1.3343297680505823e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,18442,92,1.06 [0.54-2.08],0.8612407955223975
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,18577,98,1.06 [0.56-2.03],0.8492487746161874
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,18623,144,0.67 [0.39-1.16],0.1521155008557494
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",13233,165,1.98 [1.29-3.02],0.0016491216983271
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17388,156,1.26 [0.76-2.09],0.3765440999680419
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2109,80,2.45 [1.30-4.63],0.0056241001143659
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2242,246,0.92 [0.62-1.38],0.689904185133302
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17300,68,2.22 [1.06-4.65],0.035469299458676
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2075,47,7.04 [3.78-13.09],7.2316407128475e-10
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,19045,1813,0.99 [0.85-1.15],0.8859341157086804
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,18853,503,1.05 [0.79-1.40],0.7190353586104717
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,17871,369,1.11 [0.80-1.56],0.5329195411745984
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,13953,885,1.43 [1.16-1.77],0.0007427769141756
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19621,261,1.17 [0.79-1.74],0.4258298072334255
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),18507,229,1.08 [0.70-1.67],0.7197107206477702
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Angina pectoris,17119,1284,1.03 [0.86-1.24],0.729747549274727
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,18592,314,1.02 [0.71-1.48],0.9052701428104732
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,18345,67,1.66 [0.78-3.49],0.1854035048093093
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",18508,230,1.29 [0.85-1.96],0.2275218525838159
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,10089,2370,1.20 [1.05-1.37],0.006713276255478
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,AV-block,15107,555,0.99 [0.75-1.31],0.9569855712806994
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19668,467,0.95 [0.70-1.28],0.7330586887992492
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,7940,221,2.18 [1.53-3.10],1.4599787459924269e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,14722,170,1.90 [1.20-2.99],0.0058405522845259
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",14640,88,3.12 [1.91-5.09],5.567572260845725e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,19732,61,1.21 [0.54-2.71],0.6468554923544934
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Conduction disorders,15839,1287,1.07 [0.90-1.28],0.4464787978582404
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,18121,2308,1.20 [1.05-1.37],0.0087694473802506
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,16002,7596,1.12 [1.04-1.21],0.0029322728236384
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18411,287,1.17 [0.80-1.71],0.4098118485006109
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Endocarditis,14628,76,0.56 [0.26-1.21],0.1381824667990627
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",19496,1373,1.24 [1.05-1.48],0.0125321756414073
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Hypertension,17043,6706,1.25 [1.16-1.36],3.1027385293664137e-08
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",17047,6710,1.25 [1.16-1.36],2.6166672748356124e-08
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",19595,86,0.89 [0.44-1.80],0.7532151139026512
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",10576,239,2.29 [1.62-3.25],3.003940754999621e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,10464,127,6.03 [4.77-7.63],9.017593104734129e-51
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Hypotension,19587,1314,1.47 [1.24-1.75],8.576557683861595e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,18667,123,1.32 [0.74-2.36],0.3433269487181193
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18269,2434,1.14 [1.00-1.29],0.0573600977177245
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19315,664,1.39 [1.09-1.78],0.0078391578259339
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,14977,425,1.12 [0.82-1.54],0.4762115221568559
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19185,894,1.19 [0.96-1.48],0.1041411897497345
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",16602,767,1.34 [1.06-1.68],0.0129529734505035
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19624,164,1.74 [1.08-2.79],0.0217475258119097
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",19700,338,0.89 [0.63-1.28],0.5373028215453344
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,18182,58,1.13 [0.48-2.64],0.7774143234701827
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other aneurysm,18366,88,1.34 [0.68-2.65],0.4041274927902083
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,15045,493,1.13 [0.85-1.52],0.4026616194532285
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18387,109,1.63 [0.91-2.92],0.1009548380867024
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18546,268,1.43 [0.98-2.09],0.0657618513418935
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,14743,191,1.06 [0.66-1.70],0.8095199090285294
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,18213,89,1.08 [0.55-2.15],0.8157217731442697
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,18163,39,1.20 [0.43-3.35],0.7313041492642588
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,18055,71,0.98 [0.46-2.11],0.9620748881805534
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,18264,140,1.41 [0.83-2.41],0.2055142003977631
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,15737,1185,1.24 [1.03-1.50],0.0209191262765453
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,18323,50,2.93 [1.40-6.13],0.0043956997437437
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,18881,603,1.33 [1.03-1.71],0.0304319719612045
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,19091,461,1.80 [1.36-2.38],3.3117086844818285e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",18780,796,1.28 [1.02-1.60],0.0328494721059609
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,8063,344,1.05 [0.73-1.50],0.7959985045712751
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,18734,489,1.52 [1.15-2.01],0.0036449616087335
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18483,359,0.93 [0.66-1.32],0.693824965796694
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,19124,494,1.35 [1.01-1.79],0.0409268940336855
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,19653,802,1.26 [1.01-1.58],0.0384551420872671
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,14983,431,1.20 [0.88-1.64],0.2425296968955221
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,19086,456,1.81 [1.37-2.39],3.392888787778161e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,18193,209,1.38 [0.89-2.14],0.1503831138150025
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19299,755,1.40 [1.11-1.76],0.0042423931933489
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19288,787,1.34 [1.07-1.68],0.0114285053424518
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,18642,50,0.79 [0.31-2.03],0.6250867883158083
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,18358,80,1.79 [0.91-3.53],0.0941639424532227
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,18916,265,1.40 [0.95-2.06],0.0895486333976962
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18570,279,0.97 [0.66-1.42],0.8604915704632172
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Varicose veins,18557,433,0.92 [0.67-1.25],0.5860742099876145
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18293,97,2.24 [1.30-3.85],0.0036939950981853
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19496,783,1.15 [0.92-1.45],0.2278427387246534
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19669,279,0.91 [0.62-1.34],0.6395088176909596
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",16975,1168,1.03 [0.85-1.24],0.7895023985993164
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Any mental disorder,19300,3493,0.99 [0.89-1.11],0.9107112038286532
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19644,328,0.89 [0.62-1.27],0.5162639784093732
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",16992,1185,1.13 [0.94-1.36],0.1995495917916086
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",15872,65,0.63 [0.28-1.44],0.2761492307509711
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Smoking dependency,19305,979,0.94 [0.76-1.16],0.5785570192765821
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",17016,1209,0.95 [0.79-1.15],0.592258180935176
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Vascular dementia,19031,192,0.85 [0.53-1.36],0.491847794015128
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Alzheimer disease,19735,502,1.16 [0.87-1.53],0.3126385535148499
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",12316,95,0.81 [0.41-1.62],0.550472834816129
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Bell's palsy,18196,71,1.91 [0.94-3.87],0.0737833529810368
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18548,423,0.73 [0.53-1.00],0.0493867196514182
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Cerebral cysts,19368,202,1.26 [0.80-1.97],0.3209754515763396
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19675,326,1.37 [0.97-1.94],0.0747705211102507
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,19040,72,0.91 [0.42-1.96],0.8048228519001969
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,19720,61,0.57 [0.25-1.32],0.189542754836443
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",19234,68,1.49 [0.70-3.17],0.3049495288852971
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Epilepsy,18493,246,1.01 [0.67-1.54],0.9468488939443316
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19353,1106,1.32 [1.09-1.59],0.0050564307038113
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,19686,531,0.65 [0.49-0.86],0.0025684961069285
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19184,2814,1.07 [0.95-1.21],0.2777688980598284
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,19427,43,0.67 [0.24-1.82],0.4301508365812736
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Hemiplegia,19614,265,1.53 [1.05-2.23],0.028138587229426
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Hydrocephalus,19226,60,0.74 [0.32-1.72],0.4782235456112562
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,19724,56,1.34 [0.58-3.10],0.4920612329920828
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,18186,61,0.89 [0.38-2.08],0.7909216187323753
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,18186,61,0.77 [0.33-1.77],0.5354988572177546
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Memory loss,18820,133,1.06 [0.60-1.85],0.8487995798801895
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Migraine,18480,233,1.80 [1.22-2.66],0.0030622598352352
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",19693,212,1.77 [1.18-2.66],0.0056545078307849
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Motor neuron disease,12409,166,0.93 [0.55-1.57],0.7990771605759003
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19631,52,0.73 [0.29-1.83],0.503165190020155
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",19147,1022,0.97 [0.79-1.19],0.766734263317726
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Neurological diseases,18502,3505,1.01 [0.90-1.13],0.8724508379620852
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,19210,242,0.98 [0.65-1.48],0.9207471323596008
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18461,336,0.78 [0.54-1.11],0.169088087435475
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",19671,290,1.10 [0.76-1.61],0.6130190942661431
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,14990,806,1.04 [0.82-1.31],0.7607108785824025
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,19233,67,0.83 [0.37-1.83],0.638308615835292
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,19298,132,0.75 [0.43-1.33],0.3242959315634802
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19332,177,0.69 [0.42-1.13],0.1399555774300215
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,18203,78,2.20 [1.16-4.16],0.0157845144975852
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other headache syndromes,18293,46,0.82 [0.31-2.19],0.6959685231858994
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other neurological diseases,19642,476,0.97 [0.72-1.30],0.8345310819109273
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other sleep disorders,18662,415,1.25 [0.91-1.71],0.1605010358201476
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Parkinson's disease,19704,333,0.68 [0.48-0.97],0.0353571163798744
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,19206,40,2.21 [0.94-5.20],0.0684969388343144
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,19734,77,0.44 [0.21-0.92],0.030273330291213
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Sleep apnoea,19553,359,1.34 [0.96-1.87],0.0842688733777877
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,19432,51,0.75 [0.29-1.89],0.5366501100595069
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,19723,185,0.88 [0.55-1.43],0.6165902592590695
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,18184,59,0.78 [0.33-1.84],0.5691258539111266
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,19735,507,1.14 [0.86-1.51],0.3565377909767624
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),18975,186,0.84 [0.52-1.35],0.4766591327894521
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,19206,124,1.03 [0.58-1.84],0.907841939940734
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19363,470,0.94 [0.70-1.28],0.7095918986218073
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19540,217,0.57 [0.37-0.89],0.0141305229605985
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,18683,59,1.39 [0.61-3.15],0.4292955849839451
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,18658,34,2.03 [0.77-5.37],0.1531871625410344
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",19632,63,0.76 [0.34-1.74],0.519326433757795
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,19466,186,0.75 [0.46-1.21],0.2349614246415771
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2079,50,7.84 [4.27-14.37],2.914102843560506e-11
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2545,92,2.23 [1.24-4.01],0.0075986303009585
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,19172,90,1.78 [0.95-3.35],0.0720617724709348
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19501,1201,0.94 [0.78-1.13],0.4874353611781123
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19378,754,1.05 [0.83-1.32],0.6992346363448099
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,18878,254,0.91 [0.61-1.37],0.6508982282326832
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",19678,785,0.94 [0.75-1.19],0.6215849679998733
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,19730,67,0.87 [0.39-1.94],0.7403727817580554
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,19626,733,0.91 [0.72-1.17],0.470506310153498
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",19700,420,0.74 [0.54-1.02],0.0671595991942105
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,19631,195,0.85 [0.53-1.35],0.4895032597979326
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,18714,90,1.57 [0.82-3.01],0.1706916155644021
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,18714,90,0.78 [0.39-1.56],0.4855633066642845
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,18689,65,0.85 [0.38-1.91],0.6951324356319064
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,19619,855,0.84 [0.67-1.05],0.1232830643035573
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,18997,233,0.82 [0.53-1.25],0.3583177024768741
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,18951,58,1.40 [0.61-3.21],0.4261295409754866
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19390,110,0.61 [0.33-1.15],0.1265558705729211
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,19602,322,0.82 [0.57-1.19],0.2963357670906293
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,19078,185,0.81 [0.50-1.31],0.381091029533834
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,19556,120,0.74 [0.41-1.35],0.3286234092742848
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19320,556,0.84 [0.64-1.11],0.213304421436647
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,19218,136,0.93 [0.53-1.62],0.7873300641642907
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,17674,2749,1.13 [1.00-1.28],0.0474946296155213
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,19565,285,0.82 [0.55-1.21],0.3095164298774853
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,19721,157,1.14 [0.69-1.91],0.6036065384622484
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,19094,470,1.06 [0.79-1.43],0.6873344674127638
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19362,82,0.58 [0.28-1.20],0.1393051657207022
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,19722,59,1.02 [0.44-2.35],0.9702749632065552
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,18731,107,0.72 [0.38-1.36],0.3133247801362787
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,18778,154,0.84 [0.50-1.43],0.5275283350160918
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,18442,142,0.67 [0.39-1.16],0.1548172561793694
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,18938,45,1.35 [0.52-3.45],0.5362704946033168
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",18365,65,0.48 [0.21-1.08],0.0753468492857427
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,18864,100,0.94 [0.49-1.79],0.8444761075568423
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",19009,245,0.97 [0.64-1.46],0.8768731500380311
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,18758,134,1.28 [0.74-2.20],0.3712122676524928
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,18381,81,1.16 [0.56-2.38],0.693330187276047
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,18405,105,0.99 [0.52-1.86],0.9692646267436036
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17203,2278,0.99 [0.86-1.13],0.8355445112520815
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,18706,82,0.88 [0.43-1.80],0.724338579419574
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19501,419,1.17 [0.86-1.60],0.3104457623243807
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,19150,68,0.93 [0.43-2.03],0.8581787362436225
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),19241,159,1.04 [0.62-1.73],0.8805848496382437
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,19538,97,1.08 [0.56-2.08],0.8201605638407903
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,19698,118,1.40 [0.79-2.48],0.2516920343770623
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,19623,95,1.56 [0.83-2.93],0.1692100346875431
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,19499,58,2.01 [0.95-4.27],0.0691000777858188
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,19499,58,1.42 [0.62-3.24],0.4052386382782714
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,19641,1010,1.06 [0.87-1.30],0.57209623182387
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19400,769,1.04 [0.82-1.31],0.7393514597848838
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,18755,124,0.73 [0.41-1.32],0.305384012539716
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,18708,77,1.00 [0.47-2.09],0.9915710800301444
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,19568,51,1.59 [0.66-3.81],0.2988370043305837
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19668,151,1.40 [0.84-2.35],0.1939031871506323
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,19567,50,2.52 [1.13-5.58],0.0231673332085677
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,All influenza,17515,129,1.61 [0.94-2.75],0.0847455575941745
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),17512,126,1.67 [0.97-2.86],0.0621577494044121
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),12244,85,0.93 [0.45-1.92],0.8425299787656244
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,19649,197,1.00 [0.63-1.60],0.9876141805772264
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13324,1483,0.98 [0.83-1.17],0.8335476464196693
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",13624,1465,0.97 [0.82-1.15],0.7350905879007972
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19297,151,1.20 [0.72-2.01],0.4891695942867891
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",17472,86,1.49 [0.76-2.90],0.2434624155530674
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Bronchiectasis,16529,436,1.22 [0.90-1.66],0.1924362267038469
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",16155,62,2.01 [1.00-4.05],0.049571517727874
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,18779,2686,1.03 [0.91-1.17],0.6434261360458372
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",18695,63,1.25 [0.56-2.77],0.5859534881336901
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,18744,112,0.64 [0.34-1.19],0.1605080539541556
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19486,1362,1.10 [0.92-1.31],0.2870844154701585
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,18702,70,0.87 [0.40-1.91],0.7350871468770979
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,17903,5135,1.05 [0.96-1.15],0.3115512557098411
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",18926,294,1.03 [0.71-1.50],0.879883068424227
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Early onset COPD,18223,99,1.05 [0.54-2.04],0.8827649328884762
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Emphysema,16466,373,1.19 [0.86-1.65],0.3002582543750659
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,18607,406,1.43 [1.05-1.94],0.0251070439469108
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,19511,2125,1.22 [1.06-1.40],0.0047528637665527
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,18642,441,1.44 [1.07-1.94],0.0159830492518511
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Later onset COPD,19275,1263,1.10 [0.92-1.32],0.2773721730504246
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,19719,382,1.34 [0.97-1.85],0.0724457033690362
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Nasal polyp,18718,86,0.63 [0.31-1.27],0.1952263982810552
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19491,1069,1.22 [1.00-1.48],0.0502174828110068
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,19491,2251,1.27 [1.11-1.45],0.0004441797891961
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19270,638,0.91 [0.70-1.17],0.4553178966397786
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other pleural conditions,17293,53,0.76 [0.30-1.90],0.5581848314508868
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19619,515,1.49 [1.13-1.95],0.0043968859456646
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,19625,1449,1.28 [1.08-1.50],0.0040852108538335
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pleural effusion,18359,1119,1.44 [1.19-1.73],0.0001384042162032
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pleural plaque,17457,217,1.17 [0.75-1.81],0.4958399119081913
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19270,1884,1.22 [1.05-1.41],0.0080418324691293
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,19623,286,1.47 [1.02-2.12],0.0367899046487509
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pneumothorax,17392,152,1.00 [0.59-1.70],0.9917669492687132
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pollen allergy,19726,165,0.98 [0.59-1.64],0.950730876408157
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,19177,73,1.84 [0.92-3.68],0.0856262622953498
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,12220,61,1.59 [0.74-3.40],0.2364527907063579
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19476,1054,1.21 [0.99-1.47],0.0626047291722991
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,18830,198,1.00 [0.63-1.59],0.9977509135814006
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Viral pneumonia,17629,243,1.45 [0.97-2.18],0.0677701409765609
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19308,194,1.68 [1.09-2.60],0.0190565125194122
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,6370,101,1.12 [0.59-2.13],0.7249922361676735
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,12627,52,1.46 [0.61-3.46],0.3952188300966106
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Acute appendicitis,19633,108,1.29 [0.70-2.39],0.4143358624623821
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Acute gastritis,13814,85,2.63 [1.43-4.85],0.001972819141831
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,18032,166,1.62 [1.01-2.59],0.0456152695302395
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Acute peritonitis,19333,91,2.21 [1.21-4.02],0.0098672050191016
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,18911,50,1.67 [0.68-4.10],0.264735750382521
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,14156,427,1.13 [0.83-1.54],0.4506258144202714
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",17988,122,1.34 [0.76-2.38],0.3168940765677955
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19382,122,1.32 [0.74-2.35],0.3400561967487044
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Cholecystitis,18049,183,1.17 [0.73-1.87],0.5244555680000016
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Cholelithiasis,18750,884,1.52 [1.24-1.87],7.959846227585513e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Chronic gastritis,14019,290,0.93 [0.63-1.37],0.7119120312295804
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,17912,46,0.77 [0.29-2.01],0.5870532527471499
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",19619,110,1.82 [1.01-3.26],0.0456007415096953
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Coeliac disease,18287,101,0.63 [0.32-1.23],0.1737198926159909
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Collagenous colitis,18242,86,1.63 [0.84-3.16],0.1513029381942513
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19636,141,1.32 [0.77-2.24],0.3122235120181394
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Constipation,19497,1741,1.08 [0.93-1.26],0.3155241073281704
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Crohn disease,18224,68,1.44 [0.68-3.07],0.3441201463668686
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19435,52,0.78 [0.31-1.92],0.5830860997617742
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18219,63,1.19 [0.53-2.67],0.6711803219760168
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Dental caries,19208,155,1.03 [0.61-1.73],0.9236286781194868
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,17090,2158,1.02 [0.89-1.18],0.7343842901478865
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of appendix,19657,132,1.22 [0.70-2.13],0.487297215518775
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of liver,19633,772,1.24 [0.99-1.56],0.0662502798034141
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",17587,3858,1.04 [0.94-1.16],0.4499928238992214
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19449,396,1.07 [0.77-1.48],0.6861594710246905
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19666,424,1.35 [1.00-1.84],0.0531689819007558
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19128,75,1.38 [0.67-2.83],0.3883290876295968
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,19026,47,1.05 [0.41-2.69],0.9241392193590152
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,19463,1277,1.15 [0.96-1.37],0.1252262130697891
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of tongue,19034,77,1.11 [0.53-2.33],0.7777783927623816
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",19147,1281,1.44 [1.21-1.71],4.456064537767805e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,15775,3200,1.11 [0.99-1.24],0.0798121940350134
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,13933,204,1.79 [1.16-2.75],0.0082738262387619
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19650,164,1.41 [0.87-2.31],0.165534424721495
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,19710,18,0.68 [0.14-3.31],0.6354935899754446
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,18989,128,1.50 [0.86-2.62],0.1548805634332476
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,12667,92,1.23 [0.63-2.40],0.5450795290416894
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,14212,483,1.15 [0.86-1.55],0.3426063868124556
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastric ulcer,14080,351,0.90 [0.64-1.28],0.5637831473696391
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,15963,2234,1.02 [0.89-1.17],0.7478743504755481
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,14266,537,1.13 [0.86-1.49],0.3905612905025497
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,14327,6965,1.08 [1.00-1.17],0.0601405396704141
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,GI-bleeding,19239,1053,1.24 [1.02-1.51],0.031052668439544
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,19097,44,1.16 [0.44-3.05],0.7597591262748442
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,13410,998,1.15 [0.93-1.41],0.1884940428151943
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",18919,58,3.20 [1.58-6.49],0.0012934408404788
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Hernia,17999,3067,0.96 [0.85-1.08],0.4823443340460447
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Impacted teeth,19711,17,0.82 [0.16-4.21],0.8124979484227236
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Impaction of intestines,12639,64,2.17 [1.18-4.01],0.0130122473521104
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Inguinal hernia,15860,928,0.75 [0.60-0.93],0.0077517265936671
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",15030,98,0.41 [0.22-0.78],0.0067560745119743
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,12670,95,1.19 [0.63-2.26],0.5970164104400025
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18306,120,0.64 [0.35-1.18],0.1570320866599752
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,13003,428,1.23 [0.91-1.68],0.1815358051097688
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,19711,275,1.22 [0.83-1.80],0.3022596529396537
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,18821,665,1.47 [1.16-1.88],0.0015610508406098
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,19085,929,1.37 [1.11-1.68],0.0030012705774119
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,13915,186,0.97 [0.60-1.57],0.9077542024816022
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Oesophagitis,14326,597,0.94 [0.72-1.22],0.6359102463780546
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,19686,113,0.59 [0.32-1.10],0.0954312954553531
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,15000,68,2.31 [1.17-4.55],0.0158464162536111
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,13734,1159,1.00 [0.83-1.21],0.9976299487443888
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,18163,297,1.12 [0.77-1.63],0.5389615156711076
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,17991,125,1.36 [0.77-2.38],0.2876388851011958
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,14213,1638,1.24 [1.06-1.46],0.0066237532201761
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,17772,5197,1.12 [1.02-1.22],0.0128895669057808
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,19007,182,0.75 [0.46-1.22],0.2450823626638845
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of liver,19497,636,1.30 [1.01-1.67],0.0431919809124212
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,14387,658,1.09 [0.85-1.41],0.4826456547538827
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,18040,174,1.35 [0.84-2.15],0.2114045096966667
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19601,359,1.17 [0.83-1.64],0.3760151068932068
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,14652,923,1.27 [1.03-1.57],0.0253844260448136
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,19251,1065,1.24 [1.02-1.50],0.0304358032251026
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19201,148,1.03 [0.60-1.75],0.9140682954823084
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,14353,1778,1.12 [0.96-1.30],0.1502786111428613
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),15561,1832,1.11 [0.96-1.30],0.1629648651227559
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,18960,99,0.94 [0.49-1.81],0.8565365569771979
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,18976,820,1.45 [1.17-1.80],0.0007957169769649
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",12941,366,1.43 [1.03-1.96],0.0306105216568612
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19707,22,0.65 [0.16-2.69],0.5518581578953508
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,13085,510,1.14 [0.86-1.51],0.3659267504920089
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18324,138,1.11 [0.64-1.91],0.7186521395618513
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,19723,43,0.45 [0.16-1.24],0.1220671483927818
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,19047,81,0.80 [0.39-1.67],0.5610272392924497
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Toxic colitis,18227,71,1.83 [0.92-3.64],0.0875457493070143
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,14029,300,1.12 [0.77-1.62],0.563336542679697
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,18301,145,1.32 [0.77-2.25],0.3081403473519926
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18273,117,0.95 [0.52-1.75],0.865293109758871
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Umbilical hernia,15150,218,0.76 [0.49-1.18],0.222123052948289
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,12779,204,1.96 [1.34-2.87],0.0005777031695728
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Ventral hernia,15162,230,1.23 [0.81-1.87],0.3333428915859253
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Volvulus,12650,75,0.36 [0.17-0.76],0.0076459487333646
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,19647,352,0.83 [0.58-1.17],0.2878870062799404
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19428,60,0.97 [0.42-2.25],0.9479133467236344
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,17618,142,1.26 [0.73-2.16],0.403035051102709
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,19203,696,1.57 [1.24-1.98],0.000159209377116
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18628,121,1.52 [0.87-2.68],0.1436239265814329
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,17966,490,1.08 [0.81-1.45],0.5946553219554682
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19444,263,1.32 [0.90-1.95],0.1604392005853833
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19641,460,1.10 [0.81-1.48],0.5422140934097932
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,19225,44,0.85 [0.32-2.29],0.7551269434874697
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18378,3119,1.09 [0.97-1.23],0.1315669191172825
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19366,362,0.87 [0.62-1.22],0.4174416279664258
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19252,248,0.92 [0.61-1.39],0.6787252116108946
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19409,902,1.52 [1.23-1.86],8.172001935074076e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",19718,49,0.39 [0.15-1.00],0.0495949988101275
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,17531,55,1.23 [0.53-2.84],0.6256029944590055
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19058,54,1.11 [0.47-2.66],0.8069477014249757
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19432,251,1.43 [0.96-2.12],0.0772733005783563
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,17978,502,0.85 [0.63-1.14],0.2884571030633689
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,17556,80,0.64 [0.31-1.36],0.2481830077526117
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,19663,74,1.78 [0.89-3.56],0.1018799345519601
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,18692,185,1.25 [0.79-2.00],0.343929412704852
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19564,196,1.43 [0.92-2.24],0.1152227105961572
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,19256,75,1.03 [0.49-2.19],0.92875205629403
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,17539,63,0.98 [0.43-2.22],0.956567998531752
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,19214,1738,1.01 [0.87-1.18],0.8734713014526575
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",18015,539,0.83 [0.62-1.10],0.196448798540416
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,17559,83,0.62 [0.30-1.30],0.2051866013428259
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19659,291,1.08 [0.74-1.58],0.6868574297417276
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,19244,63,0.95 [0.42-2.17],0.9110481642064572
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19609,241,1.27 [0.84-1.91],0.2526352968351759
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19676,381,0.83 [0.59-1.17],0.2914272192189652
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,17581,105,0.90 [0.47-1.72],0.7537681074311445
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,17758,282,0.75 [0.51-1.12],0.1598843970042822
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19664,369,0.84 [0.59-1.18],0.3095377841112442
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",17746,270,1.11 [0.75-1.64],0.5906489661523144
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,19712,123,1.49 [0.85-2.61],0.1596797748051861
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,16479,68,0.76 [0.34-1.69],0.5021542047554859
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,17416,5444,1.05 [0.96-1.15],0.2482695110139961
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,16216,4244,0.95 [0.86-1.05],0.336294477306586
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,16455,44,0.97 [0.36-2.59],0.947578478015984
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,16451,117,0.84 [0.46-1.54],0.5726284777621192
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,16491,157,2.19 [1.42-3.38],0.0003596038959225
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,19519,52,1.06 [0.43-2.58],0.9046910820106914
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",16457,123,0.76 [0.42-1.37],0.3566796288799723
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,13231,1259,0.87 [0.72-1.04],0.1298456166406571
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19557,210,0.88 [0.56-1.37],0.5626089948915352
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,16805,471,0.86 [0.63-1.16],0.3288862880543176
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,16001,6802,1.02 [0.94-1.10],0.7123768812809792
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,17609,103,0.70 [0.37-1.35],0.2929934609546218
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,16563,152,1.21 [0.72-2.03],0.4691214491387393
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,16842,431,0.96 [0.70-1.31],0.7954741571267017
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,18940,2606,1.00 [0.88-1.13],0.9610033522488508
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,16679,268,0.58 [0.39-0.86],0.007074621191032
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,16533,122,1.19 [0.67-2.15],0.5519504761629839
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,16512,101,0.84 [0.44-1.62],0.6068449046445042
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,19079,84,0.78 [0.38-1.60],0.492088807575232
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,13667,1695,0.93 [0.79-1.09],0.3514507104249686
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,12617,645,3.26 [2.64-4.04],1.1610981100434154e-27
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19650,640,3.42 [2.78-4.21],2.22647843530442e-31
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,12034,62,0.53 [0.23-1.24],0.1435773732349577
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),12235,263,0.97 [0.64-1.45],0.8706926370724384
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,16633,222,0.72 [0.46-1.12],0.1476233659322962
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,12380,408,0.91 [0.66-1.27],0.5889750751728081
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,16402,68,1.49 [0.73-3.05],0.2772688591320694
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,16892,558,1.24 [0.95-1.62],0.1117244074955598
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,16587,253,0.76 [0.50-1.16],0.2059582857455136
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,12354,382,0.95 [0.68-1.33],0.7626637892843326
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,16469,58,1.47 [0.66-3.31],0.3464075722283078
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",16459,48,1.03 [0.40-2.63],0.9549948835314428
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,17575,69,1.98 [0.96-4.09],0.0637266813332505
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19374,1868,0.99 [0.85-1.15],0.8741732540590632
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,18820,1314,0.98 [0.81-1.17],0.788585033664773
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19593,455,1.04 [0.77-1.41],0.7806275548734558
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14606,2634,1.01 [0.89-1.15],0.8914998579511857
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,12009,37,0.91 [0.31-2.70],0.861699738188476
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,16496,85,0.97 [0.48-1.97],0.9253261602621852
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,12035,63,1.26 [0.56-2.86],0.5759881631018338
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),12084,112,0.57 [0.30-1.07],0.0801932798233579
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,17711,205,1.26 [0.81-1.96],0.3097175894780404
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,17915,409,0.86 [0.62-1.20],0.3838111237336261
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,19720,92,1.13 [0.57-2.21],0.7279274241705422
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",17971,1637,0.97 [0.83-1.14],0.7126423910859894
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,16471,60,0.99 [0.42-2.30],0.9735650783145516
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),12100,128,0.91 [0.50-1.64],0.7473401072709648
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,16991,657,0.88 [0.68-1.13],0.3206599307950102
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,13806,1834,1.04 [0.89-1.21],0.6549480251381008
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,19101,106,1.19 [0.64-2.21],0.5749975616480641
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,19728,57,0.99 [0.42-2.33],0.9752716349408028
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,16479,68,1.05 [0.49-2.29],0.8951690846392931
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17538,1127,0.94 [0.77-1.14],0.5170883741177497
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,16499,88,1.58 [0.82-3.02],0.169865123410458
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,13724,1752,1.04 [0.89-1.22],0.6161300353701507
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,17609,103,1.17 [0.62-2.21],0.6385636579476244
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,16439,28,1.77 [0.57-5.49],0.3207974731874528
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,16499,165,1.03 [0.62-1.71],0.8953760038808795
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,16981,570,1.10 [0.84-1.45],0.4697673586407438
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19411,416,0.87 [0.63-1.20],0.392580383114545
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,16875,541,1.06 [0.80-1.40],0.6749443576863154
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19604,450,0.95 [0.70-1.29],0.7478484492217058
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,19714,54,1.36 [0.58-3.22],0.4817762480834048
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,16548,137,0.68 [0.39-1.20],0.1842080534718816
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,15388,724,1.16 [0.91-1.47],0.2330542198918491
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,16946,535,0.88 [0.67-1.17],0.3891074798228758
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],16652,241,0.56 [0.37-0.86],0.0081673891231633
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",12037,65,1.23 [0.55-2.77],0.6163048419886469
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14605,2633,1.26 [1.11-1.42],0.0003471287438463
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,12669,697,1.02 [0.80-1.31],0.8785115746818593
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,19301,306,1.03 [0.71-1.49],0.8799380988189648
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",19691,63,1.07 [0.47-2.43],0.8739255437659917
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",17505,57,0.89 [0.38-2.07],0.7900890522536068
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,12030,58,0.99 [0.42-2.35],0.986202947184292
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,16424,90,1.37 [0.71-2.67],0.3491630618173781
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,12434,462,1.03 [0.76-1.40],0.8272441381809047
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,16696,285,0.83 [0.56-1.22],0.3375050744066688
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,16566,232,1.18 [0.78-1.80],0.4354378461845439
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,16549,215,0.96 [0.62-1.51],0.8750609849291985
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,13926,59,0.66 [0.27-1.59],0.3570253797964272
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",19719,59,1.20 [0.52-2.76],0.6689169824460723
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,16879,468,0.91 [0.67-1.23],0.5223301818808783
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],19085,90,0.36 [0.18-0.74],0.0048743735244934
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,18629,2218,0.93 [0.81-1.07],0.304973590757603
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",16536,125,1.24 [0.70-2.20],0.4660202184192119
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,16903,569,0.88 [0.67-1.16],0.3750345811157284
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,18548,225,1.15 [0.75-1.77],0.5129291376324949
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,16532,198,0.73 [0.45-1.16],0.1850197296334482
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,17973,1639,1.09 [0.93-1.27],0.3148863682459288
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,17408,1074,1.16 [0.95-1.41],0.1452543190274381
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],16459,48,1.13 [0.45-2.89],0.7908979728982268
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,19102,107,1.09 [0.59-2.04],0.776683782922637
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,16554,143,1.02 [0.59-1.77],0.9344373854173196
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,16491,80,1.01 [0.49-2.12],0.9686584691852969
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),12035,63,0.79 [0.34-1.82],0.5772944725075484
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,18609,1783,2.33 [2.04-2.67],1.1538934057877477e-35
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),7974,23,0.36 [0.09-1.50],0.159606664979848
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,10112,28,0.60 [0.17-2.16],0.4329816032285017
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19461,262,0.68 [0.46-1.03],0.0661383608974389
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19289,90,1.49 [0.76-2.89],0.2449675940855216
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18546,1720,3.64 [3.29-4.02],2.4549316288694745e-144
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,19557,85,7.09 [5.31-9.45],1.6099924126467139e-40
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,19508,328,1.53 [1.09-2.15],0.0147992509897871
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Cystitis,16576,256,1.14 [0.76-1.72],0.5150395830582551
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Dialysis,16896,70,4.14 [2.97-5.77],6.074031871830536e-17
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,8642,1790,1.04 [0.89-1.21],0.6266884132901851
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,10192,108,0.64 [0.34-1.22],0.1762560100145698
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,7986,35,0.59 [0.19-1.86],0.3704109086638781
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,8434,483,0.86 [0.63-1.16],0.3290166078238608
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,16307,5225,1.27 [1.17-1.39],1.1051032600895326e-07
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,19536,64,4.81 [2.88-8.03],1.777501980510216e-09
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,6952,100,0.35 [0.19-0.65],0.0008276263229497
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,16850,274,1.33 [0.90-1.99],0.1557899723687529
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,8373,1521,1.13 [0.96-1.33],0.1517989551115767
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,10246,137,1.39 [0.82-2.36],0.2185945772350407
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),6953,101,1.36 [0.72-2.58],0.3418607346029643
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,16389,69,0.72 [0.33-1.59],0.4173116555417341
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,8822,871,1.09 [0.87-1.36],0.4564424389717255
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,6905,53,0.59 [0.24-1.43],0.2425661682592872
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,7985,34,2.04 [0.82-5.08],0.1270256673027352
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",19729,74,1.25 [0.60-2.62],0.5533062941655993
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",19722,73,1.66 [0.82-3.38],0.1575680837276667
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,18718,2398,1.10 [0.96-1.25],0.1569958692946701
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,17117,797,0.97 [0.77-1.23],0.8234409899174414
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,10128,44,0.36 [0.13-0.99],0.0483044468810412
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,19673,493,1.87 [1.43-2.44],3.7596911129622296e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,6973,121,0.78 [0.43-1.41],0.4153867761142078
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,6984,132,1.04 [0.59-1.82],0.9039241371054924
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,6978,126,1.50 [0.86-2.63],0.1523020577885935
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,19704,68,0.70 [0.31-1.54],0.3718169828003438
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,18189,1869,1.15 [0.99-1.33],0.0650539091737973
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,10181,72,1.95 [0.99-3.85],0.0549841690944418
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,8015,64,1.03 [0.45-2.33],0.9509727561048008
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",8082,131,0.99 [0.56-1.75],0.9790218101318974
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,8000,49,0.76 [0.29-2.01],0.585814794368295
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,8038,87,0.52 [0.25-1.08],0.0783581454981351
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,16900,324,1.54 [1.08-2.20],0.0181647911552204
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19340,160,2.25 [1.46-3.45],0.0002155018651785
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,8053,102,1.11 [0.58-2.10],0.7588026541260399
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,7973,22,1.43 [0.38-5.48],0.5982642600870451
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,8132,181,1.53 [0.97-2.41],0.0651721780246275
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,8033,82,1.37 [0.69-2.75],0.3711200464494211
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,8133,182,1.50 [0.95-2.37],0.084158048150052
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,19517,45,1.98 [0.82-4.78],0.1274886398462248
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",6978,126,1.31 [0.74-2.33],0.3497008025286403
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19524,2948,2.45 [2.22-2.71],3.276188911054154e-69
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",16651,75,2.83 [1.58-5.07],0.0004621545184925
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,16967,141,4.94 [3.67-6.64],3.5559161329491737e-26
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19231,32,1.35 [0.44-4.14],0.5958481525634756
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,16544,224,1.28 [0.84-1.97],0.2545803640903887
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19537,338,0.80 [0.56-1.14],0.2160078279598624
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,7985,34,0.74 [0.24-2.25],0.5900154492605053
